Clinical Trials Browser

Observational × avelumab × 30 days × Clear all

NCT06412848 2026-02-24

JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study

Active not recruiting

Carcinoma, Transitional Cell